Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five-factor model of schizophrenia. Initial validation

J P Lindenmayer1, R Bernstein-Hyman, S Grochowski

  • 1Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center-Schizophrenia Research Unit, Bronx, New York.

The Journal of Nervous and Mental Disease
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tardive dyskinesia versus tardive syndrome. What is in a name?

Parkinsonism & related disorders·2025
Same author

Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics.

Innovations in clinical neuroscience·2022
Same author

Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia.

Brain stimulation·2018
Same author

The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.

Schizophrenia research·2017
Same author

Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo.

Schizophrenia research·2013
Same author

Long-acting injectable antipsychotics: focus on olanzapine pamoate.

Neuropsychiatric disease and treatment·2010
Same journal

Efficacy and Safety of Aripiprazole in Children and Adolescents With Autism Spectrum Disorder: A Meta-Analysis.

The Journal of nervous and mental disease·2026
Same journal

Metacognitive Interpersonal Group Therapy for Adolescents With Personality Disorders: Results From the METAMIND-A Pilot Randomized Controlled Trial.

The Journal of nervous and mental disease·2026
Same journal

Activation Syndrome in Patients Diagnosed With Major Depressive Disorder for the First Time: The Role of Past Hypomania Symptoms and Atypical Depression as Risk Factors.

The Journal of nervous and mental disease·2026
Same journal

Predicting Social Motivation and Interactions in Schizophrenia: An Ecological Momentary Assessment Study.

The Journal of nervous and mental disease·2026
Same journal

Use of EQUATOR Network Templates in JNMD: The STROBE Guideline for Observational Studies.

The Journal of nervous and mental disease·2026
Same journal

Mental Illness Attributions and Their Association With Psychotherapy Change Process Expectations.

The Journal of nervous and mental disease·2026
See all related articles

This study introduces a new five-syndrome model for schizophrenia, moving beyond the positive-negative approach. This model better captures the diverse psychopathology seen in schizophrenia patients.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Psychopathology Research

Background:

  • Schizophrenic psychopathology is complex and multidimensional.
  • The positive-negative syndrome approach has limitations in capturing the full spectrum of symptoms.
  • Existing models struggle with mixed syndromes and differentiating symptom types.

Purpose of the Study:

  • To propose and validate a novel five-syndrome model for assessing schizophrenia psychopathology.
  • To address limitations of the positive-negative syndrome approach.
  • To provide a more nuanced understanding of individual patient presentations.

Main Methods:

  • Reanalysis of factor analytic procedures on 240 schizophrenia patients.
  • Utilized data from the Positive and Negative Syndrome Scale (PANSS).

Related Experiment Videos

  • Conducted three independent and comparable factor analyses to support the proposed model.

    • Main Results:

    • A five-factor solution emerged as the best fit for the psychopathological data.
    • Identified five distinct domains: negative, positive, excitement, cognitive, and depression/anxiety.
    • Data on internal consistency and initial validation using demographic and clinical variables were presented.

    Conclusions:

    • The proposed five-syndrome model offers a more comprehensive assessment of schizophrenia psychopathology.
    • This model better accounts for the heterogeneity and individual variations in patient presentations.
    • The identified domains provide a more precise mark for individual patients' psychopathological profiles.